CSIMarket
 


Neurometrix Inc   (NURO)
Other Ticker:  
 
 

NURO's Income from Cont. Operations Growth by Quarter and Year

Neurometrix Inc 's Income from Cont. Operations results by quarter and year




NURO Income from Cont. Operations (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -1.65 -0.69 -1.00 -0.33
III Quarter September -1.77 -1.61 -0.69 -0.26
II Quarter June -1.54 -1.16 -0.53 -0.85
I Quarter March -1.57 -0.96 -0.06 -0.66
FY   -6.53 -4.42 -2.28 -2.10



NURO Income from Cont. Operations fourth quarter 2023 Y/Y Growth Comment
Neurometrix Inc in the fourth quarter 2023 recorded loss from continued operations of $ -1.65 millions.

According to the results reported in the fourth quarter 2023, Neurometrix Inc achieved the best Income from Cont. Operations growth in Medical Equipment & Supplies industry. While Neurometrix Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the fourth quarter 2023.




NURO Income from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Neurometrix Inc 's fourth quarter 2023 Income from Cont. Operations $ -1.65 millions NURO's Income Statement
Neurometrix Inc 's fourth quarter 2022 Income from Cont. Operations $ -0.69 millions Quarterly NURO's Income Statement
New: More NURO's historic Income from Cont. Operations Growth >>


NURO Income from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Neurometrix Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NURO's IV. Quarter Q/Q Income from Cont. Operations Comment
Even if Neurometrix Inc in the IV. Quarter 2023 showed loss from continued operations of $ -1.65 millions, it should be point out, that current results point to improvement in contrast to the -1.77 millions in the third quarter.

Within Medical Equipment & Supplies industry Neurometrix Inc achieved highest sequential Income from Cont. Operations growth. While Neurometrix Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NURO's IV. Quarter Q/Q Income from Cont. Operations Comment
Even if Neurometrix Inc in the IV. Quarter 2023 admitted loss from continued operations of $ -1.65 millions, management mentioned, that current results point to slight up side compare to the -1.77 millions in the third quarter.

Within Medical Equipment & Supplies industry Neurometrix Inc achieved highest sequential Income from Cont. Operations growth. While Neurometrix Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Neurometrix Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Income from Cont. Operations 12 Months Ending $ -6.53 $ -5.57 $ -5.41 $ -5.03 $ -4.42
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Neurometrix Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -7 millions in the Dec 31 2023 period.
The situation is detiriorating as the cumulative loss from continued operations is getting bigger from $ -5.57 millions in TTM ending quarter Sep 30 2023 and $ -4.72774 millions for the twelve months ending in the quarter Dec 31 2022.

Neurometrix Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Neurometrix Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -7 millions in the Dec 31 2023 period.
The situation is detiriorating as the cumulative loss from continued operations is inflating from $ -5.57 millions for the period from Sep 30 2023 to Dec 31 2022 and $ -4.72774 millions from the TTM period ending Dec 31 2022.

Neurometrix Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Medical Equipment & Supplies Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
NURO's Income from Cont. Operations Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for NURO's Competitors
Income from Cont. Operations Growth for Neurometrix Inc 's Suppliers
Income from Cont. Operations Growth for NURO's Customers

You may also want to know
NURO's Annual Growth Rates NURO's Profitability Ratios NURO's Asset Turnover Ratio NURO's Dividend Growth
NURO's Roe NURO's Valuation Ratios NURO's Financial Strength Ratios NURO's Dividend Payout Ratio
NURO's Roa NURO's Inventory Turnover Ratio NURO's Growth Rates NURO's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Dec 31 2023
Align Technology inc 196.86%$ 196.862 millions
Alcon inc 190.75%$ 190.746 millions
Dexcom Inc 179.19%$ 179.194 millions
Icon Plc144.76%$ 144.764 millions
Vericel Corporation119.40%$ 119.402 millions
Novartis Ag113.57%$ 113.573 millions
Iqvia Holdings Inc 106.61%$ 106.608 millions
Davita Inc 103.75%$ 103.752 millions
Stryker Corp103.02%$ 103.020 millions
Enzon Pharmaceuticals inc 101.80%$ 101.802 millions
Surgery Partners Inc 100.43%$ 100.429 millions
Corcept Therapeutics Inc88.36%$ 88.364 millions
Intuitive Surgical Inc 81.38%$ 81.378 millions
Astrazeneca Plc81.02%$ 81.020 millions
Tactile Systems Technology Inc 77.49%$ 77.494 millions
Quest Diagnostics Inc76.72%$ 76.724 millions
Dr Reddy s Laboratories Limited76.21%$ 76.206 millions
3m Company74.40%$ 74.401 millions
Electromed Inc 71.34%$ 71.341 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com